Is routine antibiotic prophylaxis needed before dermal filler?

Strong clinical evidence does not support giving every healthy person antibiotics before routine dermal filler. Infection prevention relies on appropriate selection, deferral during active infection, hand hygiene, antisepsis, sterile product and aseptic technique.

This translation has no recorded clinical or medical-language review.

Direct answer

An antibiotic cannot compensate for failed asepsis or a contaminated product.
Unnecessary use carries allergy, adverse-effect, microbiome and antimicrobial-resistance risks.
A special cardiac or implant condition should follow the relevant current medical guideline and clinician.

Why routine use is not supported

Randomized prophylaxis evidence is lacking for most filler infections, while expert documents emphasize aseptic practice and deferral during active infection. Giving a medicine to everyone does not validate product or procedure safety. A history of a nodule or delayed swelling is not an automatic prophylaxis indication; the underlying cause needs separate assessment.

Prevention layers

Ask about active dental, sinus, skin and systemic infection and postpone elective injection over an unresolved lesion. Appropriate antiseptic, adequate contact time, a clean field, hand hygiene, gloves, sterile single-use material and correct storage complement one another. If the field is recontaminated, restore the aseptic chain rather than relying on an antibiotic.

Who defines an exception?

For selected cardiac disease, immune suppression, an implant or prior serious infection, the governing question is the person's main medical guideline, not filler routine. Confirm indication, agent, timing and risk with the relevant clinician; an online list is not a prescription. Fever, worsening pain, discharge or spreading redness needs assessment and possibly culture rather than waiting on a previously taken medicine.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Preventing Complications Associated with Dermal Fillers: An Expert Group Consensus Report
F. Urdiales-Gálvez et al. · 2017
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation
CARE board consensus authors · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review